Yüklüyor......
Cholesterol-lowering drugs: science and marketing
Long-term use of statin therapy is essential to obtain clinical benefits, but adherence is often suboptimal and some patients are also reported to fail because of ‘statin resistance'. The identification of PCSK9 as a key factor in the LDL clearance pathway has led to the development of new mono...
Kaydedildi:
| Yayımlandı: | J R Soc Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5305008/ https://ncbi.nlm.nih.gov/pubmed/28084157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0141076816681951 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|